Drug Shortage Report for GLUCAGEN
Report ID | 146717 |
Drug Identification Number | 02333619 |
Brand name | GLUCAGEN |
Common or Proper name | GLUCAGEN 1 MG |
Company Name | NOVO NORDISK CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | GLUCAGON |
Strength(s) | 1MG |
Dosage form(s) | POWDER FOR SOLUTION KIT |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | 1 x 1MG |
ATC code | H04AA |
ATC description | GLYCOGENOLYTIC HORMONES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2021-10-06 |
Actual start date | 2021-10-06 |
Estimated end date | 2021-10-13 |
Actual end date | 2021-10-13 |
Shortage status | Resolved |
Updated date | 2021-10-14 |
Company comments | Resolved, product is available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 101-2476 ARGENTIA ROAD MISSISSAUGA, ONTARIO CANADA L5N 6M1 |
Company contact information | 1 800 465 4334 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v21 | 2021-10-14 | English | Compare |